MS Walk: $1,000,500 for the 20,000 Quebec Families Affected by Multiple Sclerosis, a Canada’s disease
Montreal, May 25, 2015 – This Sunday, more than 5,000 people came together around the province to take part in the MS Walk, organized by the Multiple Sclerosis Society of Canada. Thanks to the efforts of all the participants, volunteers, and donors, $1,000,500 was raised this year. Since this annual event was launched, it has raised over $16.5 million!
Debbie Lynch-White at the
MS Walk
The MS Walk, which is held in 20 towns and cities
across the province, is a joyful, unifying event at which people with MS and
their families enjoy some unforgettable experiences! On this occasion, Debbie
Lynch-White, spokesperson of the MS Walk, was in Montreal: “They say
there’s a story behind every step. My father lived with the daily problems
caused by multiple sclerosis for almost ten years. The time I spent with him
made me a stronger person, and now I want to use this strength on behalf of all
the people who have to live with this disease. Participating in the MS Walk is
a very intense experience. My father was full of hope, and I am too! On
May 24, I was very moved to hear the stories of hundreds of other people
affected by this disease. I thank all the thousands of Quebecers who came
together in their communities so that, together, we can end MS!”
Outstanding partners
“We attribute the success of this event to the
participants’ commitment and the support of our partners such as GENZYME, a Sanofi company, presenting
partner of the MS Walk, which had 150 walkers across Canada,” said Louis Adam, Executive
Director of the Quebec Division of the MS Society.
The MS Society would also like to thank its generous national partners, without which the event could not have been such a success: GENZYME, a Sanofi company, Student Works Painting, Brink’s Canada Ltd. and Protegra.
About multiple sclerosis
Canada has the highest incidence of multiple
sclerosis in the world. MS is the most widespread neurological disease
affecting young adults in the country. It is generally diagnosed in people aged
15 to 40 years old, and its unpredictable effects last a lifetime. In 2015, the
MS Scientific Research Foundation awarded a grant to researchers seeking to
assess the effectiveness of a promising treatment for MS based on mesenchymal
stem cells. To learn more about this study, visit mssociety.ca.
- 30 -
Source :
Jeanne Sanchez-Bradley, Communications Coordinator
Multiple Sclerosis Society
of Canada, Quebec Division
514 849-7591, ext. 2245, or
1 800 268-7582 (toll-free in Quebec)
jeanne.sanchez@scleroseenplaques.ca
